Country: Միացյալ Թագավորություն
language: անգլերեն
source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Verapamil hydrochloride
Kent Pharma (UK) Ltd
C08DA01
Verapamil hydrochloride
80mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060200
PACKAGE LEAFLET:INFORMATION FOR THE USER VERAPAMIL 40 MG, 80 MG AND 120 MG TABLETS verapamil hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. 1. What Verapamil is and what it is used for 2. What you need to know before you take Verapamil 3. How to take Verapamil 4. Possible side effects 5. How to store Verapamil 6. Contents of the pack and other information WHAT VERAPAMIL IS AND WHAT IT IS USED FOR Verapamil is a calcium channel blocker, which expands your blood vessels to allow more blood to flow through them. It also acts on the nerve signals passing through the heart muscle, which can help to correct certain types of abnormal heart rhythm. Verapamil is used: - to prevent or treat angina (chest pain) and certain abnormal heart rhythms - to treat high blood pressure. WHAT YOU NEED TO KNOW BEFORE YOU TAKE VERAPAMIL DO NOT TAKE VERAPAMIL - if you are allergic to Verapamil or any of the other ingredients of this medicine (listed in section 6). - if you have a very slow heart-beat of less than 50 beats per minute. - if you suffer from heart problems including sick sinus syndrome (causing a slow heart rate). - if you suffer Lown-Ganong-Levine or Wolff-Parkinson-White syndrome (causing palpitations). - if you have had a heart attack which has been followed by a slow heart rate, low blood pressure or breathlessness. - if you have very low blood pressure due to heart problems. - if you have a WEAK HEART (causing breathlessness and tiredness). - if you have problems of conduction in the heart such as sino atrial block and read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Verapamil 80 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 80 mg of verapamil hydrochloride. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablets Biconvex, film-coated tablets engraved 2T1 or 80/0235 and plain on the reverse. 4 CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS Verapamil is indicated for the treatment and prophylaxis of angina pectoris. It may be used in the treatment and prophylaxis of paroxysmal supraventricular tachycardia, atrial fibrillation and atrial flutter; (verapamil should not be used where atrial flutter/fibrillation complicates Wolff-Parkinson-White syndrome). Verapamil may also be used in the management of mild to moderate hypertension and renal hypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration. Angina Pectoris _Adults:_ The usual dosage is 120 mg three times daily. 80 mg three times daily may be satisfactory in some patients with angina of effort. Less than 120 mg three times daily is not likely to be effective in angina at rest and variant angina. _Children: _ No data are available. Supraventricular tachycardia Adults: 40 - 120 mg three times daily according to the severity of the condition. _Children: _ Up to 2 years: Half a 40 mg tablet 2 to 3 times a day. 2 years and above: One to three 40 mg tablets two to three times daily according to age and effectiveness. Hypertension _Adults:_ The usual dosage is 160 mg twice a day. However, a minority of patients may be successfully controlled on 120 mg twice a day while others may require up to 480 mg daily given in divided doses. _Children: _ Up to 10 mg/kg/day, in divided doses, according to the severity of the disease. _Elderly: _ The adult dose is recommended unless renal or hepatic function is impaired (see Section 4.4). Elderly patients show enhanced bioavailability of verapamil and therapeutic control may be achieved with lower doses in this patient population. _Hepatic imp read_full_document